Navigating an evolving microbial landscape: emerging antimicrobial resistance trends and precision stewardship in Tianjin tertiary hospitals (2021–2023)
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1629038 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Yong-Li Wan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, National Health Commission (NHC) Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute…. Hauptthemen laut MEDLINE: Antimicrobial Stewardship, Anti-Bacterial Agents, Drug Resistance, Bacterial, Bacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate microbial distribution and antimicrobial resistance (AMR) patterns in clinical isolates from 13 tertiary hospitals and one secondary hospital in Tianjin (2021–2023) to inform precision-driven antimicrobial stewardship and infection control interventions.
Methods
In this retrospective, multicenter study, we collected routine diagnostic specimens—including sputum, fecal samples, secretions, blood, and drainage fluids. Data were processed per standardized protocols (CARSS, CHINET) and interpreted using current CLSI-M100 breakpoints. Statistical analyses were performed with SPSS 20.0 (significance set at two‐tailed P < 0.05).
Results
Sputum specimens increased from 39.1% to 43.0%, while urine samples and secretions declined. Klebsiella pneumoniae prevalence rose from 18.3% to 20.3%, whereas Escherichia coli remained stable. E. coli maintained excellent susceptibility to carbapenems and amikacin (≤2% resistance); notably, ceftazidime/avibactam resistance declined from 7.2% to 3.4% ( P = 0.005) amid a significant increase in cefepime resistance (24.4% to 29.6%, P < 0.001). K. pneumoniae exhibited parallel trends, with escalating resistance to β-lactam/β-lactamase inhibitor agents. In Pseudomonas aeruginosa , aminoglycoside, and carbapenem profiles remained stable, while ceftazidime/avibactam sensitivity markedly improved, suggesting shifts in underlying resistance mechanisms. Acinetobacter baumannii showed enhanced susceptibility to aminoglycosides, β-lactam inhibitors, and fluoroquinolones; however, carbapenem-resistant isolates continued to exhibit near-universal resistance. Among gram-positive pathogens, methicillin-resistant Staphylococcus aureus sustained near-universal β-lactam resistance with improved rifampicin sensitivity, while glycopeptides and linezolid remained fully active. Enterococcus faecalis demonstrated reduced ampicillin resistance, contrasting with E. faecium ’s near-pan-resistance to β-lactams and fluoroquinolones.
Conclusion
Evolving, species-specific AMR patterns in Tianjin hospitals highlight the urgent need for real-time, regionally stratified surveillance and molecularly informed stewardship strategies to guide targeted antimicrobial interventions and improve clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Intensive Care Unit, National Health Commission (NHC) Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
- Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin, China.
- Intensive Care Unit, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center f…
- Intensive Care Unit, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China.
- Geriatrics Department, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Intensive Care Unit, Tianjin Medical University General Hospital, Tianjin, China.
Zitieren
APA
Wan, Y. L., Han, T., Sun, Q., Wang, D., Li, J., Wang, L. J., Peng, M., Li, Y., Feng, Q. G., Liu, C. G., Xu, J., Bao, B., Su, M., Fei, Z. Y., Wang, X. L., & Liu, X. B. (2025). Navigating an evolving microbial landscape: emerging antimicrobial resistance trends and precision stewardship in Tianjin tertiary hospitals (2021–2023). Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1629038
Vancouver
Wan YL, Han T, Sun Q, Wang D, Li J, Wang LJ, et al. Navigating an evolving microbial landscape: emerging antimicrobial resistance trends and precision stewardship in Tianjin tertiary hospitals (2021–2023). Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1629038
BibTeX
@article{Wan2025,
author = {Wan, Yong-Li and Han, Tao and Sun, Qiang and Wang, Donghao and Li, Jun and Wang, Li-Jie and Peng, Min and Li, Yin and Feng, Qing-Guo and Liu, Chun-Guang and Xu, Jie and Bao, Bin and Su, Mei and Fei, Zhi-Yong and Wang, Xu-Liang and Liu, Xiao-Bo},
title = {Navigating an evolving microbial landscape: emerging antimicrobial resistance trends and precision stewardship in Tianjin tertiary hospitals (2021–2023)},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1629038}
}
EUVIMED